Patients’ compliance to clinical treatment that benefit from the Brazilian National Glaucoma Program
Autor(a) principal: | |
---|---|
Data de Publicação: | 2020 |
Outros Autores: | , , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Revista Brasileira de Oftalmologia (Online) |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-72802020000400258 |
Resumo: | Abstract Objective: To evaluate the adherence to clinical glaucoma treatment in patients that benefit from the Brazilian National Glaucoma Program and receive antiglaucomatous eye drops free of charge. Methods: This cross-sectional study included 255 patients that benefit from the Brazilian National Glaucoma Program (BNGP) and were assisted at the Altino Ventura Foundation (FAV), Pernambuco state, Brazil. The Morisky’s Adhesion Scale (MAS) was used to evaluate adhesion profile to treatment. Patients with a Morisky’s Adhesion score ≥ 6 was considered adherent to treatment. The analyzed variables included sex, educational level, distance from home to the treatment center, number of eye drops used, time since the glaucoma diagnosis, patients’ subjective classification of their quality of vision, and prevalence of other comorbidities. Results: A total of 255 patients [167 (65.4%) females] were included in this study with a mean age was 65.9 ± 13.8 years (range, 11-99 years). Adherence to clinical glaucoma treatment was seen in 155 patients (60.8%). Worse adherence to treatment was observed in female patients (p=0.034), with low education level (p=0.046), who presented other comorbidities (p=0.048), living in remote areas (p=0.038), judged their vision as satisfactory (p=0.046), and who were recently diagnosed with glaucoma (p=0.001). Conclusion: 40% of patients who benefited from the Brazilian National Glaucoma Program were not compliant to treatment. Low adhesion rate was mostly seen in female patients, socially vulnerable, living in remote areas, recently diagnosed with glaucoma, using fewer eyedrops, presenting other comorbidities, and in those that considering themselves of having a satisfactory vision. |
id |
SBO-1_ba679d9d3735ef88cfcc7aedd114032d |
---|---|
oai_identifier_str |
oai:scielo:S0034-72802020000400258 |
network_acronym_str |
SBO-1 |
network_name_str |
Revista Brasileira de Oftalmologia (Online) |
repository_id_str |
|
spelling |
Patients’ compliance to clinical treatment that benefit from the Brazilian National Glaucoma ProgramIntraocular pressureGlaucomaBlindnessPatient complianceAdherence to treatmentAbstract Objective: To evaluate the adherence to clinical glaucoma treatment in patients that benefit from the Brazilian National Glaucoma Program and receive antiglaucomatous eye drops free of charge. Methods: This cross-sectional study included 255 patients that benefit from the Brazilian National Glaucoma Program (BNGP) and were assisted at the Altino Ventura Foundation (FAV), Pernambuco state, Brazil. The Morisky’s Adhesion Scale (MAS) was used to evaluate adhesion profile to treatment. Patients with a Morisky’s Adhesion score ≥ 6 was considered adherent to treatment. The analyzed variables included sex, educational level, distance from home to the treatment center, number of eye drops used, time since the glaucoma diagnosis, patients’ subjective classification of their quality of vision, and prevalence of other comorbidities. Results: A total of 255 patients [167 (65.4%) females] were included in this study with a mean age was 65.9 ± 13.8 years (range, 11-99 years). Adherence to clinical glaucoma treatment was seen in 155 patients (60.8%). Worse adherence to treatment was observed in female patients (p=0.034), with low education level (p=0.046), who presented other comorbidities (p=0.048), living in remote areas (p=0.038), judged their vision as satisfactory (p=0.046), and who were recently diagnosed with glaucoma (p=0.001). Conclusion: 40% of patients who benefited from the Brazilian National Glaucoma Program were not compliant to treatment. Low adhesion rate was mostly seen in female patients, socially vulnerable, living in remote areas, recently diagnosed with glaucoma, using fewer eyedrops, presenting other comorbidities, and in those that considering themselves of having a satisfactory vision.Sociedade Brasileira de Oftalmologia2020-08-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-72802020000400258Revista Brasileira de Oftalmologia v.79 n.4 2020reponame:Revista Brasileira de Oftalmologia (Online)instname:Sociedade Brasileira de Oftalmologia (SBO)instacron:SBO10.5935/0034-7280.20200055info:eu-repo/semantics/openAccessAraújo,Tiago de Assis Clemente deMedeiros,Daniel MachadoPaiva,Isabel BragaAndrade,Camila Galvão deRocha,Camilla da SilvaBritto,Danielle CândidoSantos,Michel Bittencourteng2021-01-29T00:00:00Zoai:scielo:S0034-72802020000400258Revistahttps://rbo.emnuvens.com.br/rbo/indexhttps://old.scielo.br/oai/scielo-oai.phpsob@sboportal.org.br||rbo@sboportal.org.br1982-85510034-7280opendoar:2021-01-29T00:00Revista Brasileira de Oftalmologia (Online) - Sociedade Brasileira de Oftalmologia (SBO)false |
dc.title.none.fl_str_mv |
Patients’ compliance to clinical treatment that benefit from the Brazilian National Glaucoma Program |
title |
Patients’ compliance to clinical treatment that benefit from the Brazilian National Glaucoma Program |
spellingShingle |
Patients’ compliance to clinical treatment that benefit from the Brazilian National Glaucoma Program Araújo,Tiago de Assis Clemente de Intraocular pressure Glaucoma Blindness Patient compliance Adherence to treatment |
title_short |
Patients’ compliance to clinical treatment that benefit from the Brazilian National Glaucoma Program |
title_full |
Patients’ compliance to clinical treatment that benefit from the Brazilian National Glaucoma Program |
title_fullStr |
Patients’ compliance to clinical treatment that benefit from the Brazilian National Glaucoma Program |
title_full_unstemmed |
Patients’ compliance to clinical treatment that benefit from the Brazilian National Glaucoma Program |
title_sort |
Patients’ compliance to clinical treatment that benefit from the Brazilian National Glaucoma Program |
author |
Araújo,Tiago de Assis Clemente de |
author_facet |
Araújo,Tiago de Assis Clemente de Medeiros,Daniel Machado Paiva,Isabel Braga Andrade,Camila Galvão de Rocha,Camilla da Silva Britto,Danielle Cândido Santos,Michel Bittencourt |
author_role |
author |
author2 |
Medeiros,Daniel Machado Paiva,Isabel Braga Andrade,Camila Galvão de Rocha,Camilla da Silva Britto,Danielle Cândido Santos,Michel Bittencourt |
author2_role |
author author author author author author |
dc.contributor.author.fl_str_mv |
Araújo,Tiago de Assis Clemente de Medeiros,Daniel Machado Paiva,Isabel Braga Andrade,Camila Galvão de Rocha,Camilla da Silva Britto,Danielle Cândido Santos,Michel Bittencourt |
dc.subject.por.fl_str_mv |
Intraocular pressure Glaucoma Blindness Patient compliance Adherence to treatment |
topic |
Intraocular pressure Glaucoma Blindness Patient compliance Adherence to treatment |
description |
Abstract Objective: To evaluate the adherence to clinical glaucoma treatment in patients that benefit from the Brazilian National Glaucoma Program and receive antiglaucomatous eye drops free of charge. Methods: This cross-sectional study included 255 patients that benefit from the Brazilian National Glaucoma Program (BNGP) and were assisted at the Altino Ventura Foundation (FAV), Pernambuco state, Brazil. The Morisky’s Adhesion Scale (MAS) was used to evaluate adhesion profile to treatment. Patients with a Morisky’s Adhesion score ≥ 6 was considered adherent to treatment. The analyzed variables included sex, educational level, distance from home to the treatment center, number of eye drops used, time since the glaucoma diagnosis, patients’ subjective classification of their quality of vision, and prevalence of other comorbidities. Results: A total of 255 patients [167 (65.4%) females] were included in this study with a mean age was 65.9 ± 13.8 years (range, 11-99 years). Adherence to clinical glaucoma treatment was seen in 155 patients (60.8%). Worse adherence to treatment was observed in female patients (p=0.034), with low education level (p=0.046), who presented other comorbidities (p=0.048), living in remote areas (p=0.038), judged their vision as satisfactory (p=0.046), and who were recently diagnosed with glaucoma (p=0.001). Conclusion: 40% of patients who benefited from the Brazilian National Glaucoma Program were not compliant to treatment. Low adhesion rate was mostly seen in female patients, socially vulnerable, living in remote areas, recently diagnosed with glaucoma, using fewer eyedrops, presenting other comorbidities, and in those that considering themselves of having a satisfactory vision. |
publishDate |
2020 |
dc.date.none.fl_str_mv |
2020-08-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-72802020000400258 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0034-72802020000400258 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.5935/0034-7280.20200055 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Sociedade Brasileira de Oftalmologia |
publisher.none.fl_str_mv |
Sociedade Brasileira de Oftalmologia |
dc.source.none.fl_str_mv |
Revista Brasileira de Oftalmologia v.79 n.4 2020 reponame:Revista Brasileira de Oftalmologia (Online) instname:Sociedade Brasileira de Oftalmologia (SBO) instacron:SBO |
instname_str |
Sociedade Brasileira de Oftalmologia (SBO) |
instacron_str |
SBO |
institution |
SBO |
reponame_str |
Revista Brasileira de Oftalmologia (Online) |
collection |
Revista Brasileira de Oftalmologia (Online) |
repository.name.fl_str_mv |
Revista Brasileira de Oftalmologia (Online) - Sociedade Brasileira de Oftalmologia (SBO) |
repository.mail.fl_str_mv |
sob@sboportal.org.br||rbo@sboportal.org.br |
_version_ |
1752122339095478272 |